Clinical Trial Update: Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial in Korean patients with gastroesophageal reflux disease evaluating the prevalence of erosive esophagitis and qu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED